New DNA Test Is Basis for Groundbreaking IVF Refund Plan, Easing Financial Burden fo... ( NEW YORK March 5 /- The Sher Institut...)

New DNA Test Is Basis for Groundbreaking IVF Refund Plan, Easing Financial Burden for Patients

Date:3/5/2009

NEW YORK, March 5 /PRNewswire/ -- The Sher Institutes of Reproductive Medicine (SIRM) announced today the introduction of the world's first CGH-Risk Sharing Plan that guarantees qualified IVF patients a baby or offers a full refund of the clinic's medical fees. CGH is an acronym for Comparative Genomic Hybridization--a genetic process that analyzes the chromosomal integrity of the egg or embryo prior to it being transferred to a woman's uterus in the course of In Vitro Fertilization.

CGH reveals whether an egg or embryo has the correct number of chromosomes. Too many or too few (referred to as "aneuploidy") will result in either a non-viable embryo, a miscarriage or, if implanted and carried to term, a birth defect. Because aneuploidy is the most common cause of IVF failure, identifying viable embryos for transfer to the uterus can significantly boost birthrates for IVF.

"We can confidently share the financial risks of IVF because of our extraordinary successes using CGH to select one or two of the best embryos," explained Dr. Geoffrey Sher, Executive Medical Director of the Sher Institutes. "This is why, using CGH, our success rates are high, while our triplet rates are almost nil."

In peer-reviewed and published clinical data from several studies, SIRM has established that the transfer of even one CHG-normal embryo to a receptive uterus produced a baby more than 60% of the time, regardless of the age of the woman producing those eggs.

A woman participating in the CGH-Risk Sharing program undergoes ovarian stimulation, followed by retrieval of her eggs and fertilization of the eggs in the lab. The resulting embryos are then tested using the CGH process. Any resulting CHG-normal embryos will be used for transfer to the uterus, one or two at a time.

If the participant does not conceive with the first transfer and has additional frozen CGH-normal embr
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
2. APHA Urges President Bush to Reconsider Unfounded Basis for SCHIP Veto
3. The structural basis of familial hypertrophic cardiomyopathy is revealed
4. American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare
5. HSA Plans are Covering Preventive Care on a First-Dollar Basis
6. New book presents comprehensive survey of research into the molecular basis of aging
7. Twins study shows genetic basis for face and place recognition
8. MITs McGovern Institute researchers awarded $8.5M to study brain basis of autism and dyslexia
9. KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis
10. Basis created for directing and filming blood vessels
11. St. Jude gene study reveals basis of anticancer drug resistance in childhood leukemia

Post Your Comments:

New DNA Test Is Basis for Groundbreaking IVF Refund Plan, Easing Financial Burden fo...( NEW YORK March 5 /- The Sher Institut...),Health